When you see that almost half of the companies in the Pharmaceuticals industry in Canada have price-to-sales ratios (or “P/S”) above 1.2x, IM Cannabis Corp. (CSE:IMCC) looks to be giving off some buy signals with its 0.2x P/S ratio. However, the P/S might be low for a reason and it requires further investigation to determine if it’s justified.
View our latest analysis for IM Cannabis
What Does IM Cannabis’ Recent Performance Look Like?
While the industry has experienced revenue growth lately, IM Cannabis’ revenue has gone into reverse gear, which is not great. The P/S ratio is probably low because investors think this poor revenue performance isn’t going to get any better. If you still like the company, you’d be hoping this isn’t the case so that you could potentially pick up some stock while it’s out of favour.
If you’d like to see what analysts are…
